Page 32 - தேசிய விரிவான புற்றுநோய் வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
ANGLE PLC (AIM:AGL) | RNS | Angle PLC - Parsortix demonstrates oesophageal cancer utility
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Investegate |Angle PLC Announcements | Angle PLC: Parsortix demonstrates oesophageal cancer utility
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Angle PLC Announces Parsortix Demonstrates Oesophageal Cancer Utility
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Angle PLC Announces Parsortix Demonstrates Oesophageal Cancer Utility
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Exact Sciences Applauds Final Task Force Recommendation That Lowers Starting Age for Colorectal Cancer Screening to 45
National Task Force supports Cologuard® as a screening option and screening expands to an additional ˜19 million Americans
News provided by
Share this article
Share this article
MADISON, Wis., May 18, 2021 /PRNewswire/ The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendation that screening begin at age 45. Exact Sciences (NASDAQ: EXAS) Cologuard
®, referred to as sDNA-FIT, is included as a recommended screening option for all average-risk patients between the ages of 45 and 75.
Colorectal cancer is the second leading cause of cancer death in the United States, in part because many cancers go undetected until later stages when treatment options are limited.